Papers

10

Total Citations

304

H-Index

8

About

No biography available yet.

Research Focus

Key Achievements

8
H-Index
10
Papers
304
Total Citations
30
Avg Citations/Paper
🏆 Most Cited Paper
Surgical outcomes after neoadjuvant nivolumab or nivolumab with ipilimumab in patients with non–small cell lung cancer
94 citations · 2022
📈 Most Prolific Year: 2022 (2 Papers)
🤝 Key Collaborators: 56
🏛 Institutions: The University of Texas MD Anderson Cancer Center, Thoracic Surgery Foundation

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

Key Collaborators

Not generated yet